Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank57
5Y CAGR-30.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-30.4%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$133000.00-65.8%
2024$389000.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$815000.00-
2019$0.00-100.0%
2018$32000.00+14.3%
2017$28000.00-99.5%
2016$5.40M-